chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). A 10-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2 (orange cap), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1 (ORANGE CAP), SINGLE), for COVID-19 immunization. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 07Aug2022, outcome "recovering", described as "Sore throat"; RHINORRHOEA (non-serious) with onset 07Aug2022, outcome "recovering", described as "runny nose"; BODY TEMPERATURE INCREASED (non-serious) with onset 07Aug2022, outcome "recovering", described as "slightly elevated temperature". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of oropharyngeal pain, rhinorrhoea, body temperature increased. Additional information: The adverse events did not result in physician office visit or emergency room visit. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Tachycardia-Medium, Additional Details: pt felt lightheaded and dizzy, was unable to stand without passing out or some weakness. ems came and gave her an IV. she went to the emergency room.
no adverse affects reported; improperly stored VARIVAX was administered to patient; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On 13-MAY-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # S012036, expiration date: 17-APR-2021 (strength, dosage schedule and route of administration were not provided) for prophylaxis. Administered dose of vaccine was exposed to the temperature 48.2 (units not provided) for 4 hours- as recorded by digital data logger. No previous excursion was noted. No adverse effects reported.
pt recv vax 23APR96 & on 1MAR97 pt devel chickenpox;It was reported that three additional pt devel chickenpox p/receiving varicella vax @ the same med facility (WAES 97030208, 97030210, & 97030211);
He received Janssen on 3/24/21. He developed cough and congestion on 8/20/21 and had home covid test positive. We went to the urgent care on 8/26/21, and his COVID Ag was positive. His symptoms, including fevers, chills, and SOB, got worse, and he was admitted to Hospital, on 9/1/21.He is still hospitalized. (Hospital day 2)
Pt received a light dose of the Pfizer covid 19 vaccine. 0.8mls of NS was used to dilute vaccine not 1.8 mls.  A dose  of 0.3 was removed from that vial then another 1 ml of dilute was added. That diluted vaccine dose was then given to this pt. Pt contacted and reports no adverse reactions or events.
This spontaneous case, initially received on 07-Nov-2017, was reported by a other health professional (nurse) and concerns a 44 years old female. The patient's medical history not reported. The patient was not allergic to any components of the vaccine. On 05-Oct-2017, the patient was administered AFLURIA QUADRIVALENT (dose 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number:01344611A, expiry date: 30-Jun-2018). On the same day, within 1 hour after receiving vaccine, the patient experienced hives under the arm. At night, the patient also had itching, and the hives moved to the stomach and thigh. The patient was treated with BENADRYL for the events. The reporter stated that there was no itching and just a few spots were left. Hives were pretty much disappeared. The outcome of the events was reported as recovering. The reporter considered the case as non-serious.
Pt had localized redness and itching at site (R) thigh. Redness about the size of a 50 cent piece.
I experienced severe shoulder pain (frozen), unable to lift my right arm,  and I went to work but could not remain there because my arm was too painful. I went to see my PCP on 10/04/2021 and I received an injection of cortisone(recommended that it would take a few days to subside). He also suggested physical therapy but the pain was still there after receiving the cortisone injection. I ended up going to physical therapy on 10/13/2021 and then I had to go two days per week along with following up with same Orthopedic Specialist who I initially saw for the symptoms I experienced after the vaccine. He performed an X-ray of my shoulder on the first visit.
Patient was given a PREVNAR 13 injection on 3/12/15. On 3/13, her arm began to get red, warm, swollen, itchy where vaccine was administered.
Pt recvd a series of 3 doses of Engerix & exp no adverse exp, however did not convert  plan to revax;
Information has been received from a pharmacy technician concerning a 60 year old female patient who on 17-FEB-2009 was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (Lot # 662856-1559X). At the evening of 17-FEB-2009 after receiving the vaccine the patient developed an injection site reaction. The area was slightly raised, red and "hard under the skin". The patient sought unspecified medical attention. At the time of reporting the patient had not recovered. Additional information has been requested.
Malaise, severe generalized body aches especially around knees hips, jaw,ankles,  headache, nausea, chills, fever up to 101.4. Severe heartburn.  Taking dayquil 30 ml q4 hrs with 2 ibuprofen tablets q6 hrs with famotadine in AM.
Headache, Extreme tiredness, Stomach cramping and pain, Gassy, Diarrhea for 5-6 days.; Headache, Extreme tiredness, Stomach cramping and pain, Gassy, Diarrhea for 5-6 days.; Headache, Extreme tiredness, Stomach cramping and pain, Gassy, Diarrhea for 5-6 days.; Headache, Extreme tiredness, Stomach cramping and pain, Gassy, Diarrhea for 5-6 days.; Headache, Extreme tiredness, Stomach cramping and pain, Gassy, Diarrhea for 5-6 days.; This is a spontaneous report received from a contactable consumer (patient). A 41-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er2613), via an unspecified route of administration in arm left on 20Mar2021 10:30 AM as single dose for COVID-19 immunization. The patient was not pregnant. The patient medical history included POTS. The patient concomitant medications were not reported. The patient had allergies to Contrast Dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received Xyzal, Spiralactone within 2 weeks of vaccination. No other vaccine in four weeks. On 21Mar2021 at 15:15 PM, the patient experienced headache, extreme tiredness, stomach cramping and pain, gassy, diarrhea for 5-6 days. The adverse event result in Doctor or other healthcare professional office/clinic visit.The patient did not receive any treatment for the events. The outcome of the events was recovered.  Follow up closed. Information of lot/batch number was available.
102 degree fever, shivering, lethargy, sore arm, skin tingling, very dizzy
Per mother, body shakes on 4/20/17. Eyes did not roll, no fever, no temperature, no other symptoms. Child could not stand but could answer questions. Episode lasted 5-6 minutes. Happened again 4/28/17.
Arm very sore, muscles weak, horrible terrible headaches,  sore throat, cough upper respiratory infection, hair loss in patches (alopecia areata)  later uncontrollable nausea, diarrhea later a lump was found in her right breast they said it was benign but it was painful and grew rapidly so they had to surgically remove it.  Temporary VAERS E report No. 190325 has more details of everything she experienced And everything she is still going through
patient reports having soreness in left arm after vaccine.  she then reported developing pressure sensation and soreness in left clavicle region and noticed swelling in lymph node region near left clavicle.
patient developed dizziness, nausea, and vomiting the two days following the vaccination, on 4/26, day 3 she felt improved, no N/V, eating well, no dizziness, ambulating safely.
Baby had rash with positive reaction to vax, had vax and went to ER.  2/8/00 rash on face, chin, arms and legs. Patient is seen today, about 4 o'clock this morning he received vax's. About 3-4 hours later the child began to break out in diffuse rash involving the upper trunk area, the interior neck, both arms and the right thigh. He also has a few punctate lesions present on the abdominal area. Patient has history of chronic atopic dermatitis and normally has some scaliness of the skin especially in the antecubital areas bilaterally but does not usually have any significant erythema and did not have any erythema this morning when getting shots. The concern of course is some sort of allergic reaction to shot itself. He gave the child a tsp of Benadryl here. He had no other anaphylactic type of symptoms and looked to be doing well otherwise. I told the mother to treat him with Benadryl the next two days and consult us the next time he had to get immunizations.
Information has been received from a health professional concerning an approximately 62 year old female nurse who on 06-FEB-2007 was vaccinated with a dose of Zostavax. Subsequently she experienced an injection site reaction described as a 3" diameter raised red area at the injection site. Unspecified medical attention was sought. At the time of the report, the patient was recovering. There was no product quality complaint involved. Additional information has been requested. 06/22/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a health professional concerning an approximately 62 year old female with no pre-existing medical history or allergies, who on 06-FEB-2007 in the AM was vaccinated subcutaneously into the left arm with a first dose of ZOSTAVAX (Oka/Merck) (Lot # 656608/0032U). There was no illness at the time of vaccination. Subsequently the patient developed an injection site reaction described as a 3" diameter raised red area at the injection site. When the patient woke up on 07 FEB 2007 the site had become erythematous, hot to touch, 6-7 cm in circumference. It remained erythematous for two to three weeks. It was pruritic during that time. Unspecified medical attention was sought. There was no product quality complaint involved. At the time of the report, the patient had recovered. There were no lab diagnostic studies performed. No further information is expected.
Throat & Lip swelling within 5 min. post 2nd Dose of Moderna vaccine
Initial information received on 12-Jul-2018 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to case 2017SA019528. This case involves a 39 years old female patient who was exposed to vaccine ADACEL in context of maternal vaccine exposure. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported maternal vaccine exposure occurred at unknown gestation period and the patient was exposed to Diphtheria-2/Tetanus/5 AC Pertussis Vaccine at 31 weeks of pregnancy, during third pregnancy trimester for Diphtheria-2/Tetanus/5 AC Pertussis Vaccine. The date of last menstrual period was reported as 07-Dec-2017. The estimated due date is 19-Sep-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Jul-2018, the patient received a dose of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine, lot U5829AB, via intramuscular route. The patient developed a non-serious maternal vaccine exposure (exposure during pregnancy). Final diagnosis was maternal vaccine exposure. Mother did not experienced any adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
dizziness; ball in the armpit after vaccine; ball in the armpit after vaccine; This is a spontaneous report from a contactable consumer (patient).   A 34-years-old female patient received BNT162B2 (COVID-19 vaccine, Formulation: Solution for injection, Batch/Lot Number: Unknown), dose 1 via an unspecified route of administration in Left Arm on 11Sep2021 at 18:00 (Patient age at vaccination 34 year) as dose 1, single for covid-19 immunisation. The patient medical history includes COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE SODIUM) taken 75 ug and received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 12Sep2021 the patient experienced dizziness and ball in the armpit after vaccine. Pfizer have permission to contact the reporter about this event: Yes and Pfizer have permission to contact your/the patient's healthcare provider about this report: No.  Device Date: 22Sep2021. Patient didn't received treatment for dizziness. The outcome of the events was not recovered.    No follow-up attempts are needed. No further information expected.
Second dose given too early --given 21 days after first dose, no adverse event was reported by patient
pt exp dizziness, nausea, vomiting, abd pain, syncope w/in 4 days of vax;26AUG97 hypotension;
Constant pain in left wrist.  Wore a brace for a few days but the pain is still consistent. Major increase in daily hot flashes.  At the minimum, 3-5 during the course of the night and several during the day.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 regarding the patient of an unknown age and gender who on 03-JUN-2015 was vaccinated with a dose of ROTATEQ (lot number K016313) (dose and route were not provided). There was 87 hours excursion. This lot number was received on 08-APR-2015. This is one of several reports from the same reporter. Additional information is not expected as all correspondence was received.
Dizziness, NauseaVomiting, dizziness, light headedness and nause Narrative;
Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 09-MAY-2013, a physician administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 08-FEB-2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Fever 105 deg F 17 hours post injection x 2 days treated with Tylenol. Stomach cramps x 12 hrs, localized swelling and erythema x 2 days when pt reported to mother, mother stated "I forgot about you getting sick with shots-always got flu like symptoms."
Cough; This is a spontaneous report from a contactable pharmacist received from a Pfizer sponsored program. A 72-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL3302), dose 1 via an unspecified route of administration on 09Mar2021 (at the age of 72 years old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date the reporter states that a patient that got their first dose of the Pfizer covid vaccine on 09Mar2021 and after the patient got their first dose, they developed a cough, and did not go get their second dose, and is now at the pharmacy today, wanting to get the second dose and asks if they can do a second dose, states doctor told patient they would have to start the first dose again. The outcome of the events was unknown.
Death.  He was doing well,  working full time.  Came home from a full day's work.  Had chest pains, died within 1 hour.
Decreased hearing after first dose, but felt the decreased hearing was from a flight the next day. Increased hearing loss after second dose on 1/11/22. Went to ENT on 1/19 and no visual problems. on 1/21 went to Audiologist and Prednisone was recommended. This office placed her on Prednisone 20mg three times per day for 5 days w/o relief.
feels so weak; fever; Severe throbbing headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache). At the time of the report, ASTHENIA (feels so weak), PYREXIA (fever) and HEADACHE (Severe throbbing headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment detail included that the patient took Tylenol.
Covid19 breakthrough. 1st vaccine received on 03/08/2021.  90 y/o female with PMHx of HTN, HLD, Type2 diabetes, Aortic valve stenosis, Bilat hydroureteronephrosis brought to ED by daughter for confusion, productive cough, fever and postnasal drip.  Pt placed on O2 at 2L NC for SOB, Tmax 102.1 and CXR with no acute findings.  Pt treated with IV ABX, Remdesivir and steroids.
got the vaccine and still got the shingles\ suspected vaccination failure; got the shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got Shingles vaccine and still got the shingles. The patient stated vaccine works for some but not for all. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
I had painful gas pain in my chest.  Lasted most of the night and I couldn't sleep.  Went into the Pagosa Medical Group Urgent Care the next day to get checked out.  EKG came back normal.  Doc and I both thought it was gas, but we wanted to be sure it wasn't heart related.
Mistakenly administered TDaP rather than DTaP to this patient. Completely asymptomatic.
Information has been received from a 72 year old female consumer with high blood pressure "(medication controlled)," penicillin and TYLENOL allergies who on 18-APR-2008 was vaccinated SQ in the left arm with zoster vaccine live (Oka/Merck). Concomitant therapy included ZOCOR, EFFEXOR and verapamil. Subsequently, on 26-APR-2008 the patient developed back pain. On 29-APR-2008 medical attention was sought in the office. There were no lab studies performed. The patient was diagnosed with shingles. The patient was prescribed VALTREX for treatment of the shingles. No other symptoms or treatment reported. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
tiredness; diarrhea; chills; coughing; This is a spontaneous report from a contactable consumer (patient). A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), at 83 years of age, via an unspecified route of administration on 29Jan2021 at single dose, for COVID-19 immunization. The patient medical history was not reported. Patient taking other medication which were not reported. On 29Jan2021, the patient experienced diarrhea, chills, coughing and tiredness. The events were considered as non-serious. Patient was taking cough drops for coughing. The outcome of the events was recovering.   Information on the Lot/Batch Number has been requested.
Received Pfizer vaccines on 7/1, 7/22/21 COVID-19 positive by PCR on  1/9/22 admitted to hospital on 1/9/22 for left leg hematoma, asymptomatic COVID on admission
I received my vaccine in the evening and felt alright until I woke up the next morning. I typically do chores first thing on Saturdays, so I got up to do my chores and recognized that I needed to lay down less than 10 minutes into cleaning the kitchen. I felt weak, slightly dizzy, achy, and had a mild headache. I laid there from 7:30am-6:30pm only getting up to potty. I drank 100+ oz of water and a large energy drink while in bed. Over the course of the day, the headache is what became unbearable. My sinuses filled up and it turned into a migraine around 3pm. I had rice around 10am so my partner made me soup with a baguette at 6:30. I ended up calling my dad at 6:30, a 30+ year Hospital CEO, to confirm that taking a tylenol would be okay. He said it would be fine. When I took it, I felt better within 20 minutes. Within an hour I felt like I only had allergies. I was eating and watching TV. However, I was tired and wouldn't have walked far. The next morning I woke up with a severe enough headache that I took a tylenol and drank a coffee (I hear caffeine expedites medication) and by 10am I was at a hardware store buying stuff for house projects.